Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of Hypofractionated Radiotherapy in the Setting of Recurrent Diffuse Intrinsic Pontine Glioma

NCT03841435 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT03841435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03841435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of Hypofractionated Radiotherapy in the Setting of Recurrent Diffuse Intrinsic Pontine Glioma
Lead sponsor
University of Cincinnati
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2018
Completion date
March 3, 2023
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent diffuse intrinsic pontine glioma